throbber
Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 1 of 19 Page ID #:1
`
`
`
`KATHERINE E. JOHNSON, pro hac vice pending
`kjohnson3@ftc.gov
`KRISTY M. TILLMAN, pro hac vice pending
`ktillman@ftc.gov
`Federal Trade Commission
`600 Pennsylvania Avenue NW, CC-9528
`Washington, DC 20580
`(202) 326-2185 (Johnson); (202) 326-3025 (Tillman)
`Attorneys for Plaintiff
`FEDERAL TRADE COMMISSION
`Local Counsel
`DELILAH VINZON
`Cal. Bar No. 222681; dvinzon@ftc.gov
`Federal Trade Commission
`10990 Wilshire Boulevard, Suite 400
`Los Angeles, CA 90024
`Tel: (310) 824-4300; Fax: (310) 824-4380
`UNITED STATES DISTRICT COURT
`CENTRAL DISTRICT OF CALIFORNIA
`
`
`Case No.
`
`
`COMPLAINT FOR PERMANENT
`INJUNCTION AND OTHER
`EQUITABLE RELIEF
`
`
`FEDERAL TRADE COMMISSION,
`
`
`
`
`
`
`
`
`Plaintiff,
`
`v.
`
`)
`)
`)
`)
`)
`)
`
`)
`QYK BRANDS LLC d/b/a Glowyy,
`)
`
`)
`DRJSNATURAL LLC,
`)
`
`)
`RAKESH TAMMABATTULA,
`)
`individually and as an officer of QYK
`)
`BRANDS LLC, and
`)
`
`)
`JACQUELINE THAO NGUYEN,
`)
`individually and as an officer of QYK
`)
`BRANDS LLC and DRJSNATURAL LLC
`)
`
` Defendants.
`)
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 2 of 19 Page ID #:2
`
`
`
`
`
`Plaintiff, the Federal trade Commission (“FTC”) for its Complaint alleges:
`The FTC brings this action under Sections 13(b) and 19 of the Federal
`1.
`Trade Commission Act (“FTC Act”), 15 U.S.C. §§ 53(b) and 57b, and the FTC’s
`Trade Regulation Rule Concerning the Sale of Mail, Internet, or Telephone Order
`Merchandise (“MITOR” or the “Rule”), 16 C.F.R. Part 435, to obtain temporary,
`preliminary, and permanent injunctive relief, rescission or reformation of contracts,
`restitution, the refund of monies paid, disgorgement of ill-gotten monies, and other
`equitable relief for Defendants’ acts or practices in violation of Sections 5(a) and
`12 of the FTC act, 15 U.S.C. §45 (a) and 52, and in violation of MITOR, 16 C.F.R.
`Part 435.
`
`JURISDICTION AND VENUE
`This Court has subject matter jurisdiction pursuant to 28 U.S.C.
`2.
`§§ 1331, 1337(a) and 1345.
`Venue is proper in this District under 28 U.S.C. § 1391(b) (1-2), and
`3.
`15 U.S.C. § 53(b).
`
`PLAINTIFF
`The FTC is an independent agency of the United States Government
`4.
`created by statute. 15 U.S.C. §§ 41-58. The FTC enforces Section 5 of the FTC
`Act, 15 U.S.C. § 45(a), which prohibits unfair or deceptive acts or practices in or
`affecting commerce. The FTC also enforces MITOR, which requires mail,
`Internet, or telephone-based sellers to have a reasonable basis for advertised
`shipment times, and, when sellers cannot meet promised shipment times or ship
`within 30 days, to provide buyers with the option to consent to a delay in shipment
`or to cancel an order and receive a prompt refund, and to deem an order cancelled
`and make a prompt refund to buyers under certain circumstances.
`The FTC is authorized to initiate federal district court proceedings, by
`5.
`its own attorneys, to enjoin violations of the FTC Act and MITOR, and to secure
`such equitable relief as may be appropriate in each case, including rescission or
`
`-2-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 3 of 19 Page ID #:3
`
`
`
`reformation of contracts, restitution, the refund of monies paid, and the
`disgorgement of ill-gotten monies. 15 U.S.C. §§ 53(b), 57b, and 16 C.F.R. Part
`435.
`
`DEFENDANTS
`Defendant QYK Brands LLC (“QYK” or “Glowyy”) is a California
`6.
`Limited Liability Company, with its principal place of business located at 9
`MacArthur Place, # 302, Santa Ana, California. QYK does business as Glowyy
`through the website glowwy.com and owns the trademark for Dr. J’s Natural.
`QYK transacts or has transacted business in this District and throughout the United
`States. At all times material to this Complaint, acting alone or in concert with
`others, QYK has advertised, marketed, or sold merchandise to consumers
`throughout the United States.
`DRJSNATURAL LLC (“Dr. J’s Natural”) is a California Limited
`7.
`Liability Company, with its principal place of business located at 10517 Garden
`Grove Boulevard, Garden Grove, California.
`Defendant Rakesh Tammabattula (“Tammabattula”) is the Chief
`8.
`Executive Officer of QYK. At all times material to this Complaint, acting alone or
`in concert with others, Tammabattula has formulated, directed, controlled, had the
`authority to control, or participated in the acts and practices of QYK, including the
`acts and practices set forth in this Complaint. Defendant Tammabattula resides in
`this District and, in connection with the matters alleged herein, transacts or has
`transacted business in this District and throughout the United States.
`Defendant Jacqueline Thao Nguyen, who works under the moniker
`9.
`“Dr. J,” is married to Rakesh Tammabattula, and is the Chief Operating Officer of
`QYK, and the founder and Chief Executive Officer of Dr. J’s Natural. At all times
`material to this Complaint, acting alone or in concert with others, Dr. J has
`formulated, directed, controlled, had the authority to control, or participated in the
`acts and practices of QYK and Dr. J’s Natural, including the acts and practices set
`
`-3-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 4 of 19 Page ID #:4
`
`
`
`forth in this Complaint. Defendant Dr. J resides in this District and, in connection
`with the matters alleged herein, transacts or has transacted business in this District
`and throughout the United States.
`COMMERCE
`10. At all times material to this Complaint, Defendants have maintained a
`substantial course of trade in or affecting commerce, as “commerce” is defined in
`Section 4 of the FTC Act, 15 U.S.C. § 44.
`DEFENDANTS’ BUSINESS ACTIVITIES
`11. Tammabattula and Dr. J, through QYK (collectively, the “QYK
`Defendants”) own multiple brands and companies that sell skin care, health,
`beauty, personal care, and wellness products. The QYK Defendants promote and
`sell products on qyk.us, qyksonic.com, glowyy.com, and drjsnatural.com.
`12. Beginning on or around March 12, 2020, the QYK Defendants offered
`Dr. J’s Natural (and other branded) hand sanitizer through the website
`glowyy.com. The QYK Defendants market four sizes of Dr. J’s Natural hand
`sanitizer: a 3.3 oz bottle for $5.99; a 4.0 oz bottle for $5.99; a 10 oz bottle for
`$9.99; and a 16 oz bottle for $12.99. The QYK Defendants also offer Personal
`Protective Equipment (such as face masks and shields), surface wipes, and
`disinfectants.
`
`The QYK Defendants’ Shipment Claims
`13. During the early weeks of the pandemic quarantine in the United
`States, obtaining hand sanitizer as quickly as possible was paramount for many
`consumers; this high demand made products difficult to find.
`In order to capitalize on this demand, beginning in early March 2020,
`14.
`the QYK Defendants started advertising they had hand sanitizer “In Stock” and
`“Ships Today.”
`
`-4-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 5 of 19 Page ID #:5
`
`
`
`15. The QYK Defendants disseminated these advertisements on
`Instagram and in targeted ads through GQ.com, for example, and in response to
`web searches for hand sanitizer.
`16. For example, the following appeared in response to a Google search
`on or about March 12, 2020:
`
`17. The QYK Defendants’ promises that hand sanitizer “Ships Today”
`were false.
`18. For example, one consumer ordered from glowyy.com on March 12,
`2020 following a Google search for hand sanitizer, which led to an advertisement
`from the QYK Defendants representing that glowyy.com had “Hand Sanitizers in
`Stock” and that the order would ship the same day it was purchased.
`19. Despite this promise, the consumer’s order did not ship until April 12,
`2020. Moreover, when the consumer finally received her order on April 16, 2020,
`the sanitizer she received was a different brand and smaller size than she had
`ordered.
`20. Beginning in April through May 2020, the QYK Defendants’ website
`stated that shipment of hand sanitizer orders would be within seven (7) days. For
`example, on April 13, 2020, glowyy.com stated that customers should expect
`processing times of five to seven (5 to 7) days but indicated that orders would ship
`as soon as they were processed. Similarly, on April 19, 2020, glowwy.com stated
`that orders of hand sanitizer placed that day would ship by April 22, i.e. within
`
`-5-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 6 of 19 Page ID #:6
`
`
`
`three (3) days. And on May 15, glowyy.com stated that the processing time for
`hand sanitizer was three to seven (3 to 7) days. The following screenshots are
`from April 13, 19, and May 15, 2020, respectively:
`a. Glowyy Outbreak Essentials webpage dated April 13, 2020:
`
`
`b. Glowyy 10 oz Hand Sanitizer Gel webpage dated April 19, 2020:
`
`
`
`-6-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 7 of 19 Page ID #:7
`
`
`
`c. Glowyy Advanced Formula Hand Sanitizer webpage dated May 15, 2020:
`
`
`
`21. However, while the above advertisements were available, consumers
`still reported receiving online ads stating that orders would be shipped in less time.
`For example, one consumer reports receiving an online advertisement promising a
`one to two (1 to 2) day shipment time on April 19, 2020.
`22. The QYK Defendants’ promises of shipment times of seven days or
`less were false. In numerous instances, the QYK Defendants generated a United
`States Postal Services (“USPS”) shipping label and tracking number within one
`day, but waited weeks or months to deliver the ordered products to the post office
`for shipping.
`23. For example, a consumer placed an order for eight (8) bottles of hand
`sanitizer on April 5, 2020. She received an email confirmation from Glowyy that
`same day which included a tracking number, and stated, “Your order is on the
`way.”
`
`-7-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 8 of 19 Page ID #:8
`
`
`
`24. Despite ongoing inquiries and communications from the consumer,
`the QYK Defendants had not shipped the order by May 5, 2020, when she asked
`Glowyy to cancel the order and issue a refund. Glowyy failed to provide a refund.
`25. For hand sanitizer purchased between approximately mid-March and
`the end of April, numerous consumers reported their orders did not arrive at the
`mail carrier’s facility and ultimately were not shipped until weeks or months after
`their purchase.
`In numerous instances, the QYK Defendants did not ship one or more
`26.
`pieces of ordered merchandise, including hand sanitizer, within the timeframes
`represented in their advertisements and on their websites.
`In numerous instances, when the QYK Defendants failed to ship one
`27.
`or more pieces of ordered merchandise, including hand sanitizer, within stated time
`frames, the QYK Defendants did not offer consumers the opportunity to consent to
`a delay in shipping or to cancel their orders and receive refunds.
`The QYK Defendants’ Refusal to Issue Prompt Refunds and Cancel Orders
`28. Numerous consumers complained to QYK about shipping delays via
`emails to the company and on its social media web pages.
`In numerous instances, representatives from QYK told consumers
`29.
`ordered merchandise would ship soon, but did not offer the consumer the option of
`canceling and receiving a refund or of consenting to an indefinite delay, or any
`delay.
`30. After not receiving their merchandise, or after complaining and being
`informed of the delay, many consumers attempted to cancel their orders and
`requested refunds.
`In most instances, QYK refused, if it responded at all. Instead, the
`31.
`QYK Defendants informed consumers they could not issue a refund once the
`shipping label had been created.
`
`-8-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 9 of 19 Page ID #:9
`
`
`
`In some instances, the QYK Defendants informed consumers the only
`32.
`way to get a refund was to refuse delivery of the shipment, which would require
`the consumers to personally intercept the mail carrier at the time of delivery.
`33. The QYK Defendants shipped merchandise to consumers even after
`the consumers had cancelled the order and demanded a refund.
`In numerous instances, when the QYK Defendants failed to ship one
`34.
`or more pieces of ordered merchandise, including hand sanitizer, within stated time
`frames, and also failed to offer consumers the required opportunity to either
`consent to a delay in shipping or to cancel their orders and receive refunds, the
`QYK Defendants did not deem the orders cancelled and issue refunds.
`35. Dozens of consumers complained about these practices to QYK,
`Defendant Dr. J, online sites like Trustpilot.com, and the FTC, particularly during
`the initial months of the COVID-19 pandemic.
`The Individuals’ Knowledge
`In an April 2, 2020 YouTube video titled “Your Order Updates for Dr.
`36.
`J’s Natural Hand Sanitizer/Is Glowyy Legit?” Dr. J publicly addressed the
`complaints and concerns about the delays in shipping.
`37. She admitted some consumers had been waiting more than seven days
`due to “uncertainty on manufacturing side,” [sic] and that it had been “difficult to
`source the bottle or the pump.”
`38. On April 3, 2020, Tammabattula stated that QYK “saw the surge in
`searches for hand sanitizer [in early March]. That’s when we started ramping up
`our production.”
`39. A few days later Tammabattula publicly stated that the company only
`had enough raw ingredients for about two weeks’ worth of hand sanitizer, and
`“timelines for production have been extended six to eight weeks” compared to the
`typical two or three weeks.
`
`-9-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 10 of 19 Page ID #:10
`
`
`
`40. On April 9, 2020, Tammabattula reiterated there were not enough raw
`ingredients for hand sanitizer: “From the alcohol to the polymers that we use to
`gel the product to the plastic bottles that we use to package the product.”
`41. Despite these public acknowledgments, the QYK Defendants
`continued to make the same shipment timing claims on the glowyy.com website,
`specifically the QYK Defendants continued to advertise that the products were in
`stock and would ship within one to two (1 to 2) days, or three to seven (3 to 7)
`days, and continued to take orders with these shipment time claims throughout
`April, May, and June 2020.
`Dr. J’s Natural Defendants’ Deceptive COVID-19 Prevention Claims
`42. Dr. J’s Natural and Dr. J (collectively, “Dr. J’s Natural Defendants”)
`offer a product called “Basic Immune IGG” through their website, drjsnatural.com.
`The product is part of their “COVID Essentials” line. Dr. J’s Natural Defendants
`sell Basic Immune IGG for $89.
`43. Basic Immune IGG is the brand name used by the Dr. J’s Natural
`Defendants for a product developed by Entera Health, Inc. under the registered
`trademark Immunolin.
`44. Basic Immune IGG/Immunolin is a serum-derived bovine
`immunoglobulin concentrate.
`In English, on its website, drjsnatural.com, Dr. J’s Natural Defendants
`45.
`market Basic Immune IGG as a “protein powder” that can maintain “healthy
`immune function” and a “healthy immune system.”
`46. Similar claims also appear on Dr. J’s Natural Instagram page. For
`example, on June 1, 2020, Dr. J’s Natural posted a “COVID-19 Special Offer,”
`which offered a discount for Dr. J’s Basic Immune IGG, and promised that the
`product would “boost up your immune system.”
`In videos, however, the Dr. J’s Natural Defendants make very
`47.
`different representations. Specifically, they claim ingesting Basic Immune IGG
`
`-10-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 11 of 19 Page ID #:11
`
`
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`can prevent transmission of COVID-19; that Basic Immune IGG is FDA approved
`for that purpose; and that Basic Immune IGG has been clinically tested and
`approved for prevention of COVID-19 transmission.
`48. The strongest claims appear in Vietnamese language videos. For
`example, on or about April 2, 2020, Dr. J appeared on a newscast on Saigon
`Entertainment Television (SET), a California-based station broadcasting to
`Vietnamese speakers in the United States. In that appearance she told consumers
`that Basic Immune IGG could “prevent” COVID-19 by boosting the immune
`system, explaining:
`
`Dr. J: let’s say if I sit next to Mr. Do Dung or someone else or happen
`to touch something and get infected with COVID-19, at least I have
`already had more antibodies that can detect the invasion and cling to
`and attack the coronavirus. It’s like, the antibodies will say, “hey,
`bacteria are penetrating the body, let’s come and fight it off.”
`
`49. Dr. J further claimed that mixing Basic Immune IGG with drinking
`water could ward off COVID-19. For instance, during the same newscast she
`explained:
`
`
`Dr. J: . . . the immunoglobulin antibody therapy that I take with this
`powder, like how I drank and showed you earlier, is to increase my
`existing antibodies and make them stronger. The product helps
`strengthen the army of soldiers already present in my body. Then, let's
`say if one coronavirus happens to infiltrate my body, I already have
`about five hundred thousand antibodies, thanks to this powder. They
`would cling to and bite that coronavirus, push it out and kill it. . . .
`And now if Mr. Do Dung or our dearest audience haven’t taken this
`antibody powder yet, it means that if the coronavirus enters your
`
`-11-
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 12 of 19 Page ID #:12
`
`
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`body, Mr. Do Dung and you only have 5,000 antibodies while I have
`500,000 of them, because I have been taking this antibody powder.
`
`50. She also represented, in close proximity to these claims during the
`same newscast, that Basic Immune IGG has been FDA approved and undergone
`clinical trials. For example, in response to the question “Is it guaranteed that we
`will stay safe?” Dr. J responds, “It’s guaranteed, because there is FDA’s
`verification and approval.” She also states: “Our parent company is the only
`company obtaining the registered trademark for this antibody product from the
`FDA []. We have conducted clinical studies, involving the extraction and
`cultivation of antibodies taken from cow blood, which is then made into this
`antibody powder.”
`51. Dr. J makes similar claims in Vietnamese on SET during her regularly
`broadcast show, the Dr. J’s Natural Show.
`52. Dr. J also made similar claims in English-language videos appearing
`on YouTube. For example, in a June 8, 2020 video in which Dr. J responds to
`questions regarding COVID-19 from consumers, she addresses the question “What
`is the best preventative measure to take now?” Her response—use Dr. J’s hand
`sanitizer and take Basic Immune IGG. Basic Immune IGG will boost the immune
`system, “so just in case you get infected with the virus, then your body will be able
`to fight back and destroy all the Coronavirus that is entering your body.”
`53. Similarly, in a June 11, 2020 English-language YouTube video titled,
`“How Does Immune IGG Work,” Dr. J claimed that Basic Immune IGG had been
`clinically tested, was a “prevention” for COVID-19, and had a “patent” from the
`FDA.
`
`In the June 11 video, Dr. J claimed Basic Immune IGG helps the body
`54.
`recognize viruses, “especially Coronavirus” and the product has “tons of clinical
`data.”
`
`-12-
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 13 of 19 Page ID #:13
`
`
`
`In fact, Basic Immune IGG/Immunolin is not an FDA-approved
`55.
`treatment or preventative for COVID-19.
`56. Moreover, there are no published adequate and well controlled clinical
`studies of Basic Immune IGG, Immunolin, or a serum-derived bovine
`immunoglobulin for use to effectively treat, prevent, or reduce the risk of
`contracting COVID-19. In fact, there are no published studies of any kind for
`Basic Immune IGG or Immunolin.
`VIOLATIONS OF THE MAIL, INTERNET, OR TELEPHONE ORDER
`MERCHANDISE RULE
`57. MITOR, 16 C.F.R. Part 435, prohibits sellers from soliciting any
`order for the sale of merchandise ordered through the mail, via the Internet or by
`telephone “unless, at the time of the solicitation, the seller has a reasonable basis to
`expect that it will be able to ship any ordered merchandise to the buyer” either
`“[w]ithin that time clearly and conspicuously stated in any such solicitation; or [i]f
`no time is clearly and conspicuously stated, within thirty (30) days after receipt of
`a properly completed order from the buyer.” 16 C.F.R. § 435.2(a)(1).
`“Receipt of a properly completed order” means “where the buyer
`58.
`tenders full or partial payment . . . the time at which a seller receives both said
`payment and an order from the buyer containing all of the information needed by
`the seller to process and ship the order.” 16 C.F.R. § 435.1(c).
`“Shipment” means the act of physically placing the merchandise in
`59.
`the possession of a carrier. 16 C.F.R. § 435.1(e).
`60. Where a seller is unable to ship merchandise within the time stated in
`the solicitation or within 30 days, if no time is given, the seller must offer to the
`buyer “clearly and conspicuously and without prior demand, an option either to
`consent to a delay in shipping or to cancel the buyer’s order and receive a prompt
`refund.” 16 C.F.R. § 435.2(b)(1).
`
`-13-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 14 of 19 Page ID #:14
`
`
`
`a. Any such offer “shall be made within a reasonable time after the
`seller first becomes aware of its inability to ship,” but in no event
`later than the time stated or within 30 days if no time is stated. 16
`C.F.R. § 4352(b)(1).
`b. The offer must fully inform the buyer of the buyer’s right to cancel
`and provide a definite revised shipping date or inform the buyer
`that the seller cannot make any representation regarding the length
`of the delay. 16 C.F.R. § 435.2(b)(1)(i).
`61. A seller must “deem an order cancelled and . . . make a prompt refund
`to the buyer whenever the seller receives, prior to the time of shipment, notification
`from the buyer cancelling the order pursuant to any option [under MITOR] . . . [or]
`[t]he seller fails to offer the option [to consent to a delay or cancel required by
`§ 435.2(b)(1)] and has not shipped the merchandise” within the time required by
`MITOR. 16 C.F.R. § (c)(4), (5).
`62. Pursuant to Section 18(d)(3) of the FTC Act, 15 U.S.C. § 57a(d)(3),
`and 16 C.F.R. Part 435.2 a violation of the Rule constitutes an unfair or deceptive
`act or practice in violation of Section 5(a) of the FTC Act, 15 U.S.C. § 45(a).
`Count I- MITOR Violations
`(QYK Defendants)
`In numerous instances, when the QYK Defendants:
`a. represent they will ship purchased goods within the one to two (1
`to 2) days, three to five days (3 to 5), or three to seven (3 to 7)
`days, they do not have a reasonable basis to expect to ship the
`goods within the timeframes they promise;
`b. fail to ship orders within the timeframe required by MITOR, they
`also fail to offer customers the opportunity to consent to a delay in
`shipping or to cancel their order and receive a prompt refund;
`
`63.
`
`-14-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 15 of 19 Page ID #:15
`
`
`
`c. fail to ship orders within the timeframe required by MITOR and
`fail to offer consumers the opportunity to consent to a delay in
`shipping or to cancel their order, they do not cancel those orders or
`provide consumers a prompt refund;
`d. receive cancellation and refund requests from consumers pursuant
`to any option under MITOR, they do not deem those orders
`cancelled or provide a prompt refund.
`64. Defendants’ practices as alleged in Paragraph 63 violate MITOR, 16
`C.F.R. § 435.2(a), (b), and (c), and therefore are unfair or deceptive acts or
`practices in violation of Section 5 of the FTC Act, 15 U.S.C. § 45(a).
`VIOLATIONS OF THE FTC ACT
`65. Section 5(a) of the FTC Act, 15 U.S.C. § 45(a), prohibits “unfair or
`deceptive acts or practices in or affecting commerce.”
`66. Misrepresentations or deceptive omissions of material fact constitute
`deceptive acts or practices prohibited by Section 5(a) of the FTC Act.
`67. Section 12 of the FTC Action, 15. U.S.C. § 52, prohibits the
`dissemination of any false advertisement in or affecting commerce for the purpose
`of inducing, or which is likely to induce, the purchase of food, drugs, devices,
`services, or cosmetics. For purposes of Section 12 of the FTC Act, 15 U.S.C. § 52,
`Basic Immune IGG is a “food” or “drug” as “food” and “drug” are defined in
`Section 15(b) and (c) of the FTC Act, 15 U.S.C.§ 55(b) and (c).
`Count II- Deceptive Shipping Claims
`(QYK Defendants)
`In numerous instances in connection with the advertising, marketing,
`68.
`promotion, offering for sale, or sale of goods, specifically hand sanitizer and
`related products, the QYK Defendants have represented, directly or indirectly,
`expressly or by implication, that they:
`
`-15-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 16 of 19 Page ID #:16
`
`
`
`a. will ship goods the same day they are purchased, or will ship
`goods within seven (7) days;
`b. have goods in stock and ready to ship; and
`c. will deliver the goods consumers order.
`In truth and in fact, in numerous instances in which the QYK
`69.
`Defendants have made the representations set forth in Paragraph 68, the QYK
`Defendants:
`
`a. failed to ship goods the same day they were purchased, or failed to
`ship goods within seven (7) days;
`b. did not have sufficient goods in stock to make shipments as
`advertised; or
`c. delivered materially different goods.
`70. Therefore, Defendants’ representations set forth in Paragraph 68 are
`false, misleading, or unsubstantiated, and constitute deceptive acts or practices in
`violation of Section 5(a) of the FTC Act, 15 U.S.C. § 45(a).
`Count III- Deceptive COVID-19 Prevention Claims
`(Dr. J’s Natural Defendants)
`71. Through the means described in Paragraphs 42-56, the Dr. J’s Natural
`Defendants have represented, directly or indirectly, expressly or by implication
`that Basic Immune IGG can effectively treat, prevent transmission of, or reduce the
`risk of contracting COVID-19.
`72. The representations set forth in Paragraph 71 are false, misleading or
`were not substantiated at the time the representations were made.
`73. Therefore, the making of the representations as set forth in Paragraph
`71 of this Complaint constitutes a deceptive act or practice and the making of false
`advertisements, in or affective commerce, in violation of Section 5(a) and 12 of the
`FTC Act, 15. U.S.C. §§ 45(a) and 52.
`
`
`-16-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 17 of 19 Page ID #:17
`
`
`
`Count IV-False Establishment Claims
`(Dr. J’s Natural Defendants)
`74. Through the means described in Paragraphs 42-56, Dr. J’s Natural
`Defendants have represented, directly or indirectly, expressly or by implication
`that Basic Immune IGG has been clinically proven and FDA-approved to treat,
`prevent transmission of, or reduce the risk of contracting COVID-19.
`75. The representations set forth in Paragraph 74 are false.
`76. Therefore, the making of the representations as set forth in Paragraph
`74 of this Complaint constitutes a deceptive act or practice and the making of false
`advertisements, in or affecting commerce, in violation of Sections 5(a) and 12 of
`the FTC Act, 15 U.S.C. §§ 45(a) and 52.
`CONSUMER INJURY
`77. Consumers are suffering, have suffered, and will continue to suffer
`substantial injury as a result of Defendants’ violations of the FTC Act and MITOR.
`In addition, Defendants have been unjustly enriched as a result of their unlawful
`acts or practices. Absent injunctive relief by this Court, Defendants are likely to
`continue to injure customers, reap unjust enrichment, and harm the public interest.
`THIS COURT’S POWER TO GRANT RELIEF
`78. Section 19 of the FTC Act, 15 U.S.C. § 57b, and MITOR authorize
`this Court to grant such relief as the Court finds necessary to redress injury to
`consumers resulting from Defendants’ violations of MITOR, including the
`rescission or reformation of contracts and the refund of money.
`79. Section 13(b) of the FTC Act, 15 U.S.C. § 53(b), empowers this Court
`to grant injunctive and such other relief as the Court may deem appropriate to halt
`and redress violations of any provision of law enforced by the FTC. The Court, in
`the exercise of its equitable jurisdiction, may award ancillary relief, including
`rescission or reformation of contracts, restitution, the refund of monies paid, and
`
`-17-
`
` 1
` 2
` 3
` 4
` 5
` 6
` 7
` 8
` 9
` 10
` 11
` 12
` 13
` 14
` 15
` 16
` 17
` 18
` 19
` 20
` 21
` 22
` 23
` 24
` 25
` 26
` 27
` 28
`
`
`

`

`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 18 of 19 Page ID #:18
`Case 8:20-cv-01431-JLS-KES Document 1 Filed 08/04/20 Page 18 of 19 Page ID #:18
`
`1
`2
`
`3
`
`4
`5
`6
`
`the disgorgement of ill-gotten monies, to prevent and remedy any violation of any
`provision of law enforced by the FTC.
`
`PRAYER FOR RELIEF
`
`Wherefore, Plaintiff FTC, pursuant to Sections 13(b) and 19 of the FTC Act,
`15 U.S.C. §§ 53(b), 57b, MITOR, and the Court’s own equitable powers, requests
`that the Court:
`
`Award Plaintiff such preliminary injunctive and ancillary relief as
`A.
`7
`8 may be necessary to avert the likelihood of consumer injury during the pendency
`9
`of this action and to preserve the possibility of effective final relief, including but
`10
`not limited to, temporary and preliminary injunctions;
`
`11
`
`B.
`
`Enter a permanent injunction to prevent future violations of the FTC
`
`12 Act by Defendants;
`
`C.
`
`Award such relief as the Court finds necessary to redress injury to
`
`consumers resulting from Defendants’ violations of the FTC Act and MITOR,
`
`including restitution, rescission or reformation of contracts, the refund of money or
`
`return of property, the payment of damages, and public notification respecting the
`
`rule violation or the unfair or deceptive act or practice; and
`
`D.
`
`Award Plaintiff the costs of bringing this action, as well as such other
`
`and additional relief as the Court may determine to bejust and proper.
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25 Dated: August 4, 2020
`
`26
`27
`28
`
`Respectfully submitted,
`
`ALDEN F. ABBOTT
`
`General Counsel
`
`
`
`hac vice pending
`THE

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket